Renovaro Inc. has announced the filing of a new patent application titled "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions." This development strengthens the company's intellectual property portfolio, focusing on real-time, reproducible analytics across distributed computing environments. The patent application supports Renovaro's scalable drug discovery and diagnostics business by protecting its machine learning infrastructure for multi-modal biomedical data integration and predictive analytics.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。